Saturday, 28 September 2013

Janssen signs licensing agreement with PATH for development of HIV-1 drug « New Drug Approvals

Janssen signs licensing agreement with PATH for development of HIV-1 drug « New Drug Approvals:

'via Blog this'

No comments:

Post a Comment